Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Approval Study of the R3 Biolox Delta Ceramic Acetabular System - Europe

NCT03566082 is registered in ClinicalTrials.gov with Smith & Nephew Orthopaedics AG as lead sponsor.

NCT NCT03566082
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03566082 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Approval Study of the R3 Biolox Delta Ceramic Acetabular System - Europe
Lead sponsor
Smith & Nephew Orthopaedics AG
Phase
Observational
Overall status
Completed
Start date
May 28, 2009
Completion date
October 15, 2021
Enrollment
135 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

degenerative joint disease of hip